Table 1 Demographic and clinical characteristics of patients with systemic sclerosis (SSc)
Sample ID | ||||||
|---|---|---|---|---|---|---|
Parameters | SSc1 | SSc2 | SSc3 | SSc4 | SSc5 | SSc6 |
Age | 51 | 58 | 56 | 78 | 65 | 72 |
Sex | F | F | F | F | F | F |
RP duration (months) | 108 | 168 | 36 | 720 | 180 | 288 |
Disease duration (months) | 108 | 168 | 24 | 48 | 36 | 288 |
Skin involvement | lcSSc | lcSSc | lcSSc | lcSSc | lcSSc | lcSSc |
mRSS score | 17 | 4 | 14 | 14 | 5 | 17 |
VCP pattern | Active | Active | Active | Active | Active | Active |
ANA | Positive | Positive | Positive | Positive | Positive | Positive |
Autoantibody | Scl70 | CENP | Fibrillarin | CENP | CENP | CENP |
Organ involvement | Yes (lung, esophagus) | No | No | No | No | No |
Therapy | Ca2+ antagonists, ACE inhibitors, immunosuppressors, ERAs, aspirin, vitamin D | Aspirin, aminaphtone, angiotensin receptor blockers | Aminaphtone, vitamin D | Aspirin, steroids, ACE inhibitors, aminaphtone, MTX | Aspirin | Aminaphtone, vitamin D |